Mereo BioPharma Group PLC (MREO)
3.64
-0.18
(-4.71%)
USD |
NASDAQ |
Nov 15, 09:57
Mereo BioPharma Group Cash and Short Term Investments (Quarterly): 87.43M for June 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 87.43M |
| March 31, 2024 | 48.66M |
| June 30, 2023 | 53.12M |
| December 31, 2022 | 68.18M |
| June 30, 2022 | 92.68M |
| June 30, 2022 | 92.68M |
| December 31, 2021 | 127.27M |
| June 30, 2021 | 152.37M |
| June 30, 2021 | 152.37M |
| December 31, 2020 | 31.98M |
| June 30, 2020 | 69.94M |
| June 30, 2020 | 69.94M |
| December 31, 2019 | 21.43M |
| Date | Value |
|---|---|
| June 30, 2019 | 45.77M |
| June 30, 2019 | 45.77M |
| December 31, 2018 | 34.95M |
| June 30, 2018 | 48.26M |
| June 30, 2018 | 48.26M |
| December 31, 2017 | 71.01M |
| June 30, 2017 | 73.61M |
| June 30, 2017 | 73.61M |
| December 31, 2016 | 66.10M |
| June 30, 2016 | 93.67M |
| June 30, 2016 | 93.67M |
| December 31, 2015 | 18.15M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
21.43M
Minimum
Dec 2019
152.37M
Maximum
Jun 2021
82.16M
Average
69.94M
Median
Jun 2020
Cash and Short Term Investments (Quarterly) Benchmarks
| NuCana PLC | 14.72M |
| TC BioPharm (Holdings) PLC | 1.238M |
| Adaptimmune Therapeutics PLC | 214.79M |
| Biodexa Pharmaceuticals PLC | 6.394M |
| Autolus Therapeutics PLC | 705.94M |